2 healthcare stocks that could outperform the FTSE 100 index
2 mins. to read
Robert Stephens, CFA, discusses the outlook for AstraZeneca and Smith & Nephew.
Robert Stephens, CFA
Why Lloyds and Aviva could offer long-term income investing appeal
2 mins. to read
Robert Stephens, CFA, discusses the dividend potential of FTSE 100 shares Lloyds and Aviva.
Why high inflation and an uncertain economic outlook make Imperial Brands and Severn Trent more appealing
2 mins. to read
Robert Stephens, CFA, discusses the outlook for two defensive FTSE 350 stocks with growing dividends.
Why BAT and Unilever shares offer dividend investing appeal
2 mins. to read
Robert Stephens, CFA, discusses the prospects for two high-yielding FTSE 100 index shares.
2 FTSE 100 fallers with recovery potential
2 mins. to read
Robert Stephens, CFA, discusses the long-term prospects for two declining stocks.
Why WPP and LSE offer FTSE 100 outperformance potential after mixed recent returns
2 mins. to read
Robert Stephens, CFA, discusses the prospects for two FTSE 100 stocks that have produced very different return profiles over recent months.
Why easyJet and IHG’s share prices may be undervalued
2 mins. to read
Robert Stephens, CFA, discusses the prospects for two travel and leisure stocks.
Can the Glencore and BHP share prices continue to outperform the FTSE 100?
2 mins. to read
Robert Stephens, CFA, discusses the outlook for BHP and Glencore.
Why these 2 falling property stocks offer value for money
2 mins. to read
Robert Stephens, CFA, discusses the outlook for two unpopular FTSE 350 property companies.
Why Tesco and Sainsbury’s share prices could offer investment appeal
2 mins. to read
Robert Stephens, CFA, discusses the outlook for Tesco and Sainsbury’s shares.